- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2015
- Public Summary Document (PSD) November 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2015 PBAC Meeting - Word
Ibrutinib – November 2015
Ibrutinib: oral capsule, 140 mg, Imbruvica®
Last updated
18 March 2016